FDA: IV fluid shortage exacerbated by hurricane damage to Puerto Rico is expected to improve

The FDA expects IV fluid shortages to improve early this year after a leading manufacturer of IV saline bags — Baxter International — announced all of its facilities in Puerto Rico have returned to the commercial power grid.

While saline supplies were low prior to Hurricane Maria's landfall, the storm significantly worsened the shortage by disrupting operations and knocking out power at Baxter's three manufacturing plants on the island.

The shortages have affected hospitals nationwide. To mitigate saline shortages, many hospitals have employed strategies such as administering drugs through syringes or in pill form rather than intravenously.

However, now that Baxter's facilities are connected to the commercial power grid, the FDA is confident that the shortages will soon subside.

"Given the improvements we’ve seen over the last few weeks, I’m optimistic that supplies of IV saline and amino acids will increase over the next few weeks and the stress of the shortage will begin to abate, even if the shortages will not be fully resolved immediately," said FDA Commissioner Scott Gottlieb, MD, in a press release.

More articles on supply chain:
FDA ends 2017 with 46 new drug approvals – the most in 2 decades
California city could be first in US to use drones to deliver blood
Mold-contaminated antibiotic recalled nationwide: 5 things to know

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars